Search Results

There are 10440 results for: content related to: Why Is Guanfacine Recommended by AHS and ANN for Migraine Prevention?

  1. You have full text access to this OnlineOpen article
    The behavioural response of mice lacking NK1 receptors to guanfacine resembles its clinical profile in treatment of ADHD

    British Journal of Pharmacology

    Volume 171, Issue 20, October 2014, Pages: 4785–4796, Katharine Pillidge, Ashley J Porter, Julia A Dudley, Yuan-Chen Tsai, David J Heal and S Clare Stanford

    Version of Record online : 26 SEP 2014, DOI: 10.1111/bph.12860

  2. Antihypertensive Efficacy of Guanfacine and Methyldopa in Patients with Mild to Moderate Essential Hypertension

    The Journal of Clinical Pharmacology

    Volume 31, Issue 4, April 1991, Pages: 318–326, Dr. Michael F. Wilson, Dr. Jack Blackshear, Dr. Oscar A. Parsons, Dr. William R. Lovallo and Dr. Pershottam Mathur

    Version of Record online : 8 MAR 2013, DOI: 10.1002/j.1552-4604.1991.tb03712.x

  3. You have free access to this content
    The physiological and pharmacological role of presynaptic alpha- and beta-adrenoceptors in man.

    British Journal of Clinical Pharmacology

    Volume 20, Issue 6, December 1985, Pages: 649–658, MJ Brown, AD Struthers, JM Burrin, L. Di Silvio and DC Brown

    Version of Record online : 26 JUL 2012, DOI: 10.1111/j.1365-2125.1985.tb05124.x

  4. You have free access to this content
    COMPARISON OF THE ACTIONS OF CENTRALLY AND PERIPHERALLY ADMINISTERED CLONIDINE AND GUANFACINE IN THE RABBIT: INVESTIGATION OF THE DIFFERENCES

    British Journal of Pharmacology

    Volume 77, Issue 4, December 1982, Pages: 641–647, N.D. BARBER and J.L. REID

    Version of Record online : 19 JUL 2012, DOI: 10.1111/j.1476-5381.1982.tb09342.x

  5. Effects of clonidine and guanfacine in essential hypertension

    Clinical Pharmacology & Therapeutics

    Volume 36, Issue 5, November 1984, Pages: 588–594, Csaba Farsang, Károly Varga, Lidia Vajda Sándor Alföldi and Judit Kapocsi

    Version of Record online : 6 NOV 1984, DOI: 10.1038/clpt.1984.226

  6. Effects of the vasodilator endralazine given with the antihypertensive agent guanfacine on heart rate and blood pressure of spontaneously hypertensive rats and normotensive dogs

    Journal of Pharmacy and Pharmacology

    Volume 35, Issue 5, May 1983, Pages: 293–298, R. SALZMANN, W. GERBER CH. PALLY and G. SCHOLTYSIK

    Version of Record online : 12 APR 2011, DOI: 10.1111/j.2042-7158.1983.tb02937.x

  7. Signaling mechanism underlying α2A-adrenergic suppression of excitatory synaptic transmission in the medial prefrontal cortex of rats

    European Journal of Neuroscience

    Volume 38, Issue 3, August 2013, Pages: 2364–2373, Feng Yi, Shu-Su Liu, Fei Luo, Xue-Han Zhang and Bao-Ming Li

    Version of Record online : 23 MAY 2013, DOI: 10.1111/ejn.12257

  8. Pharmacokinetics and pharmacodynamics of guanfacine extended release in adolescents aged 13–17 years with attention-deficit/hyperactivity disorder

    Clinical Pharmacology in Drug Development

    Volume 3, Issue 4, July/August 2014, Pages: 252–261, Patrick Martin, Lawrence Satin, Bradley D. Vince, Americo F. Padilla, Carla White, Mary Corcoran, Annette Stevenson and James Ermer

    Version of Record online : 17 MAY 2014, DOI: 10.1002/cpdd.124

  9. Antihypertensive Efficacy of Guanfacine and Prazosin in Patients with Mild to Moderate Essential Hypertension

    The Journal of Clinical Pharmacology

    Volume 30, Issue 12, December 1990, Pages: 1081–1087, Andrew Lewin, Michael H. Alderman and Pershottam Mathur

    Version of Record online : 8 MAR 2013, DOI: 10.1002/j.1552-4604.1990.tb01849.x

  10. You have free access to this content
    [3H]-GUANFACINE: A RADIOLIGAND THAT SELECTIVELY LABELS HIGH AFFINITY α2-ADRENOCEPTOR SITES IN HOMOGENATES OF RAT BRAIN

    British Journal of Pharmacology

    Volume 75, Issue 2, February 1982, Pages: 401–408, BEVYN JARROTT, WILLIAM J. LOUIS and ROGER J. SUMMERS

    Version of Record online : 19 JUL 2012, DOI: 10.1111/j.1476-5381.1982.tb08801.x

  11. Chronic Treatment with Antidepressant Drugs and ECT Differentially Modifies the Hypothermic Action of Clonidine and Guanfacine

    Pharmacology & Toxicology

    Volume 60, Issue 4, April 1987, Pages: 305–311, Wojciech Danysz, Bruce G. Minor, Abdul Mohammed, Olgierd Pucilowski, Adam Plaznik, Wojciech Kostowski, Claes Post and Trevor Archer

    Version of Record online : 25 MAR 2009, DOI: 10.1111/j.1600-0773.1987.tb01757.x

  12. Use of ECG Restitution (Beat-to-Beat QT-TQ Interval Analysis) to Assess Arrhythmogenic Risk of QTc Prolongation with Guanfacine

    Annals of Noninvasive Electrocardiology

    Volume 19, Issue 6, November 2014, Pages: 582–594, Anthony A. Fossa, Meijian Zhou, Antoine Robinson, Jaideep Purkayastha and Patrick Martin

    Version of Record online : 9 SEP 2014, DOI: 10.1111/anec.12202

  13. Adaptive Changes in α-2 Adrenoceptor Mediated Responses: Analgesia, Hypothermia and Hypoactivity

    Pharmacology & Toxicology

    Volume 65, Issue 2, August 1989, Pages: 143–151, Bruce G. Minor, Wojciech Danysz, Gösta Jonsson, Abdul K. Mohammed, Claes Post and Trevor Archer

    Version of Record online : 25 MAR 2009, DOI: 10.1111/j.1600-0773.1989.tb01145.x

  14. You have free access to this content
    Effect of guanfacine on pituitary hormones in man.

    British Journal of Clinical Pharmacology

    Volume 10, Issue S1, February 1980, Pages: 151S–156S, I. Lancranjan

    Version of Record online : 26 JUL 2012, DOI: 10.1111/j.1365-2125.1980.tb04923.x

  15. Pharmacokinetics of a Guanfacine Extended-Release Formulation in Children and Adolescents with Attention-Deficit–Hyperactivity Disorder

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 27, Issue 9, September 2007, Pages: 1253–1262, Dr. Samuel W. Boellner, Mr. Michael Pennick, Ms. Kimberly Fiske, Mr. Andrew Lyne and Dr. Amir Shojaei

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.27.9.1253

  16. You have free access to this content
    Guanfacine and Guanfacine Extended Release: Treatment for ADHD and Related Disorders

    CNS Drug Reviews

    Volume 13, Issue 4, Winter 2007, Pages: 465–474, David J. Posey and Christopher J. McDougle

    Version of Record online : 7 DEC 2007, DOI: 10.1111/j.1527-3458.2007.00026.x

  17. The Bioavailability and Pharmacokinetics of Guanfacine After Oral and Intravenous Administration to Healthy Volunteers

    The Journal of Clinical Pharmacology

    Volume 27, Issue 10, October 1987, Pages: 762–767, Susan H. Carchman, James T. Crowe Jr. and George J. Wright

    Version of Record online : 8 MAR 2013, DOI: 10.1002/j.1552-4604.1987.tb02993.x

  18. Development and validation of a simple, sensitive and accurate LC-MS/MS method for the determination of guanfacine, a selective α2A-adrenergicreceptor agonist, in plasma and its application to a pharmacokinetic study

    Biomedical Chromatography

    Volume 27, Issue 12, December 2013, Pages: 1708–1713, Xiaonan Li, Ning Li, Xiaolin Sun, Wei Yang, Yu Dai, Jie Xu, Wei Zhang, Chunfeng Wang, Suilou Wang and Xijing Chen

    Version of Record online : 8 JUL 2013, DOI: 10.1002/bmc.2983

  19. Guanfacine in essential hypertension: Effects during rest and isometric exercise

    Clinical Pharmacology & Therapeutics

    Volume 35, Issue 5, May 1984, Pages: 604–609, Thomas Hedner, Gunnar Nyberg and Tore Meilstrand

    Version of Record online : 9 MAY 1984, DOI: 10.1038/clpt.1984.83

  20. Clonidine and guanfacine in hypertension

    Clinical Pharmacology & Therapeutics

    Volume 37, Issue 3, March 1985, Pages: 271–276, Adesh K Jain, Anand Hiremath, Ronald Michael, J R Ryan and F G McMahon

    Version of Record online : 23 MAR 1985, DOI: 10.1038/clpt.1985.39